Peripartum cardiomyopathy occurring in a patient previously treated with doxorubicin.
We present a 28-year-old primigravida woman in whom congestive heart failure developed 3 months after delivery of a neonate. The patient underwent doxorubicin treatment 10 years previously. The combined cardiotoxicity of prior doxorubicin treatment and pregnancy is considered, and the importance of careful follow-up of cardiac function during pregnancy and postpartum in patients previously treated with doxorubicin is stressed.
Katz
A
A
Department of Internal Medicine D, The Chaim Sheba Medical Center, Tel-Hashomer, Israel.
Goldenberg
I
I
Maoz
C
C
Thaler
M
M
Grossman
E
E
Rosenthal
T
T
D000328:Adult; D000903:Antibiotics, Antineoplastic / Q000009:adverse effects* / Q000627:therapeutic use; D002311:Cardiomyopathy, Dilated / Q000139:chemically induced* / Q000628:therapy; D004317:Doxorubicin / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D011247:Pregnancy; D011644:Puerperal Disorders / Q000139:chemically induced*; D013997:Time Factors
D000903:Antibiotics, Antineoplastic; D004317:Doxorubicin